Quantcast

Latest Biomarkers Stories

2014-10-16 12:29:56

ZUG and ROTKREUZ, Switzerland, Oct. 16, 2014 /PRNewswire/ -- Cardiorentis AG, a privately held biopharmaceutical company, today announced a collaboration with Roche to establish the therapeutic efficacy and safety of Ularitide, the Company's investigational drug for acute heart failure (AHF). Under the terms of the collaboration, Cardiorentis will incorporate Roche's advanced in vitro diagnostic tests into its TRUE-AHF Phase III Study to characterize the pharmacological properties of...

2014-10-14 08:31:11

BOSTON, Oct. 14, 2014 /PRNewswire/ -- Boston Strategics Corporation (BSC), an integrated clinical-stage drug research and development (R&D) company, Boston, MA, today announced that it has entered into an agreement with Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics. In collaboration with MRL, BSC designs and manages for pharmaceutical drug development programs to...

2014-10-09 08:27:36

ProMark(TM) Validated to Predict Disease Aggressiveness and Empower Informed Treatment Decisions CAMBRIDGE, Mass., Oct. 9, 2014 /PRNewswire/ -- Metamark announced today the nationwide availability of ProMark(TM), the first-of-its-kind protein-based biopsy test designed to improve the accuracy of prognosis for men diagnosed with prostate cancer. For the 205,000 men annually with indeterminate Gleason scores (3+3 and 3+4), ProMark can help identify aggressiveness of the disease....

2014-10-07 12:31:04

GHENT, Belgium and MADRID, October 7, 2014 /PRNewswire/ -- MyCartis today announced the launch of Evalution(TM), a multiplex biomarker analysis platform for the life sciences research market. Evalution(TM) is MyCartis' digital multiplex analysis platform tailored to clinical research and pharmaceutical markets and designed to analyze a broad range of protein and nucleic acid-based biomarkers, delivering high quality data and rapid results. Evalution(TM) provides an...

2014-10-02 12:31:01

Surveyed Payers' Formulary Placement of Novel Agents is Likely to be Influenced by a Companion Biomarker Test, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 2, 2014 /PRNewswire/ -- Decision Resources Group finds that biomarker driven prescribing is likely to positively influence perceptions of emerging drugs for both oncologists and payers. Results of a survey of 100 medical oncologists and 30 medical directors and pharmacy directors of managed care organizations...

2014-09-29 16:25:57

Additional Tests to Demonstrate the Importance of Utilizing Multiple Biological Pathways to Provide Patients, Physicians with Confidence to Make Educated Treatment Decisions CAMBRIDGE, Mass., Sept. 29, 2014 /PRNewswire/ -- Metamark announced today the expansion of its prostate cancer test services to now include the PROGENSA(®) PCA3 assay, a urine-based test that can help confirm negative prostate biopsies, and ERG, a companion test to the company's existing PTEN assay. These tests...

2014-09-26 08:25:21

DUBLIN, Sept. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The isolation and characterisation of CTCs and CNAs are two of the fastest growing areas of research in the cancer field. Growth is also being seen in the translation of this research...

2014-09-26 08:25:19

DUBLIN, Sept. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental...

2014-09-24 08:29:06

AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer VIENNA, BRNO, Czech Republic and BERLIN, September 24, 2014 /PRNewswire/ -- The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers. Colon cancer is...

2014-09-18 08:29:25

Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept. 18, 2014 /PRNewswire/ -- Australian biomarker discovery company Minomic International Ltd will today launch an important US trial of its MiStat(TM) prostate cancer screening test, planning to achieve US Food and Drug Administration (FDA) regulatory approval upon completion. Minomic's proprietary MiStat(TM) technology is a screening assay capable of identifying the presence of a...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related